Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04485507 · ClinicalTrials.gov registry record · NA

COgnitive Intervention to Restore Attention Using Nature Environment

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
74
Enrollment target

NCT04485507 is a NA study that has completed, run by Indiana University. The registered enrollment target is 74 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04485507, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target

Study Summary

Heart failure is a prevalent and serious public health concern with the growing aging population. Patients with heart failure often experience attention impairment that decreases their ability to perform self-care and diminishes their health-related quality of life. In past studies, 15 - 27% of heart failure patients had attention impairment. Attention is fundamental to human activities including self-care management of heart failure. However, cognitive interventions focusing on attention are scarce in heart failure literature. This study focuses on developing a novel cognitive intervention specifically targeting improved attention and testing its efficacy on improving attention, self-care, and health-related quality of life. The investigators in this study are asking the following 3 questions: 1) does the newly developed cognitive intervention using immersive virtual reality technology (Nature-VR) improve attention compared with the control condition (Urban-VR)?; 2) does Nature-VR intervention improve HF self-care and health-related quality of life compared with Urban-VR control condition?; and 3) are selected biological factors associated with attention function in HF? The virtual reality-based cognitive intervention (Nature-VR) can be an efficacious intervention for the patients to use and enjoy without burdening already reduced attention. This study has great potential to improve attention and prevent attention impairment, thereby leading to healthier lives among heart failure patients.

Interventions

  • OTHER Nature-VR
  • OTHER Urban-VR

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2020-07-01
Est. Completion 2022-06-08
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT04485507

The ClinicalTrials.gov registry entry for NCT04485507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Nature-VR is the first listed.

NCT04485507 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04485507 about?

NCT04485507 is a clinical study titled "COgnitive Intervention to Restore Attention Using Nature Environment". Heart failure is a prevalent and serious public health concern with the growing aging population. Patients with heart failure often experience attention impairment that decreases their ability to perform self-care and diminishes their health-related quality of life. In past studies, 15 - 27% of hear...

What is the current status of trial NCT04485507?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2020-07-01. Estimated completion is 2022-06-08.

What interventions are being tested in trial NCT04485507?

The interventions under investigation include: Nature-VR (OTHER), Urban-VR (OTHER).

Who is sponsoring clinical trial NCT04485507?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.